Project Number 1R44AG054404-01 Agency/Funding Organization NIA Funding Year 2016 View Full Project Details for DEVELOPMENT OF NOVEL INHIBITORS OF C1Q FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator YEDNOCK, TED Principal Investigator First Name TED Principal Investigator Last Name YEDNOCK Awardee Organization ANNEXON, INC. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-14-088: Direct Phase II SBIR Grants to Support Biomedical Technology Development FY Overall Cost $1,213,915 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
